This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Herman Kattlove, MD, MPH; Alessandro Liberati, MD; Emmett Keeler, PhD; Robert H. Brook, MD, ScD
RAND Santa Monica, Calif

JAMA. 1995;274(5):382.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—The purpose of our article was to determine which tests and procedures were appropriate for the detection and treatment of early breast cancer. We defined appropriateness by the effect of treatment on outcomes such as survival and quality of life. We did a cost-effectiveness analysis to permit decisions to be made concerning which procedures should be provided if resources become increasingly limited. Although screening mammography for women younger than 50 years can detect tumors at an earlier stage, there is no evidence from available clinical trials that this translates into improved survival. We cannot afford to perform procedures for which there is no benefit. The money saved by not providing routine screening to women younger than 50 years could be used for screening older women, screening high-risk younger women, and providing breast-conserving surgery for those in whom it is appropriate.

We considered only the four options of screening, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?